Bank of Nova Scotia’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,143,287
Closed -$86.4M 1137
2026
Q1
$86.4M Buy
1,143,287
+1,049,115
+1,114% +$78.9M 0.15% 125
2025
Q4
$7.01M Sell
94,172
-22,284
-19% -$1.63M 0.01% 560
2025
Q3
$7.86M Buy
116,456
+90,888
+355% +$6.03M 0.01% 458
2025
Q2
$1.67M Sell
25,568
-116,754
-82% -$7M ﹤0.01% 711
2025
Q1
$8.79M Buy
142,322
+44,710
+46% +$2.96M 0.02% 381
2024
Q4
$7.04M Buy
97,612
+67,832
+228% +$5.3M 0.01% 472
2024
Q3
$2.43M Sell
29,780
-89,307
-75% -$7.14M ﹤0.01% 616
2024
Q2
$8.84M Sell
119,087
-72,861
-38% -$5.46M 0.02% 388
2024
Q1
$15M Buy
191,948
+143,706
+298% +$10.7M 0.03% 327
2023
Q4
$3.45M Buy
48,242
+19,660
+69% +$1.37M 0.01% 565
2023
Q3
$1.98M Sell
28,582
-40,399
-59% -$3.05M 0.01% 582
2023
Q2
$5.59M Buy
68,981
+45,168
+190% +$3.69M 0.01% 361
2023
Q1
$1.92M Sell
23,813
-193,716
-89% -$15.6M 0.01% 555
2022
Q4
$16.3M Buy
217,529
+194,886
+861% +$13.9M 0.04% 270
2022
Q3
$1.46M Sell
22,643
-114,936
-84% -$7.96M ﹤0.01% 720
2022
Q2
$9.54M Buy
137,579
+105,727
+332% +$7.85M 0.02% 378
2022
Q1
$2.45M Sell
31,852
-17,149
-35% -$1.23M ﹤0.01% 766
2021
Q4
$3.75M Sell
49,001
-17,273
-26% -$1.27M 0.01% 769
2021
Q3
$4.89M Buy
66,274
+27,443
+71% +$2.06M 0.01% 639
2021
Q2
$2.59M Sell
38,831
-9,783
-20% -$654K ﹤0.01% 761
2021
Q1
$3.62M Buy
48,614
+4,793
+11% +$364K 0.01% 650
2020
Q4
$3.19M Sell
43,821
-34,554
-44% -$2.44M 0.01% 605
2020
Q3
$5.21M Sell
78,375
-165,889
-68% -$10.5M 0.01% 460
2020
Q2
$13.9M Buy
244,264
+15,906
+7% +$780K 0.05% 257
2020
Q1
$8.02M Buy
228,358
+131,969
+137% +$6.28M 0.03% 344
2019
Q4
$5.03M Buy
96,389
+41,592
+76% +$2.07M 0.01% 523
2019
Q3
$2.77M Buy
54,797
+4,257
+8% +$209K 0.01% 605
2019
Q2
$2.43M Sell
50,540
-496
-1% -$22.9K 0.01% 568
2019
Q1
$2.47M Sell
51,036
-7,064
-12% -$319K 0.01% 581
2018
Q4
$2.39M Buy
58,100
+2,709
+5% +$111K 0.01% 563
2018
Q3
$2.27M Buy
55,391
+25,818
+87% +$1.04M 0.01% 615
2018
Q2
$1.18M Sell
29,573
-5,337
-15% -$205K 0.01% 640
2018
Q1
$1.3M Sell
34,910
-28,888
-45% -$1.17M 0.01% 675
2017
Q4
$2.73M Sell
63,798
-5,212
-8% -$208K 0.01% 515
2017
Q3
$2.53M Sell
69,010
-14,596
-17% -$589K 0.01% 515
2017
Q2
$3.79M Sell
83,606
-902
-1% -$39.8K 0.02% 479
2017
Q1
$3.6M Buy
84,508
+57,678
+215% +$2.35M 0.02% 477
2016
Q4
$1.08M Buy
26,830
+500
+2% +$19.3K 0.01% 472
2016
Q3
$1.02M Buy
26,330
+5,800
+28% +$219K 0.01% 393
2016
Q2
$710K Hold
20,530
﹤0.01% 432
2016
Q1
$708K Hold
20,530
﹤0.01% 414
2015
Q4
$794K Hold
20,530
﹤0.01% 423
2015
Q3
$803K Buy
20,530
+8,030
+64% +$318K ﹤0.01% 342
2015
Q2
$475K Hold
12,500
﹤0.01% 377
2015
Q1
$412K Buy
+12,500
New +$384K ﹤0.01% 401

Other funds holding HOLX

Bank of Nova Scotia's HOLX Position: Q2 2026 in Review

Bank of Nova Scotia sold out of Hologic (HOLX) in Q2 2026, closing a stake of 1,143,287 shares — an estimated $86.4M sold.

Bank of Nova Scotia first reported a position in HOLX in Q1 2015 and held it in 45 quarters. The position peaked at $86.4M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Bank of Nova Scotia reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Bank of Nova Scotia sold 1,143,287 Hologic shares in Q2 2026, an estimated $86.4M.
  • Bank of Nova Scotia first reported a position in Hologic in Q1 2015 and held it in 45 quarters.
  • Bank of Nova Scotia's Hologic position peaked at $86.4M in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.